Mony J. de Leon, Ed.D., is director of the Brain Health Imaging Institute (BHII). Trained in gerontology and neuroscience, his research focuses on the clinical detection of brain changes underlying cognitive dysfunction, and the characterization of mechanisms contributing to misfolded brain proteins and tissue damage in aging and Alzheimer’s disease (AD). His team’s post-mortem validated biomarker discoveries of hippocampal atrophy and brain glucose metabolism deficits predicting clinical outcomes have contributed to the current standard diagnostic assessment of AD.